Literature DB >> 1480666

Pentostatin: future directions.

W D Klohs1, A J Kraker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1480666

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  5 in total

1.  A novel transition state analog inhibitor of guanase based on azepinomycin ring structure: Synthesis and biochemical assessment of enzyme inhibition.

Authors:  Saibal Chakraborty; Niti H Shah; James C Fishbein; Ramachandra S Hosmane
Journal:  Bioorg Med Chem Lett       Date:  2010-11-27       Impact factor: 2.823

2.  Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.

Authors:  R T DeGraw; B D Anderson
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

3.  Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs.

Authors:  T B McClanahan; D P Ignasiak; B J Martin; T E Mertz; K P Gallagher
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

4.  Modulation by nicotinamide adenine dinucleotide of sympathetic and sensory-motor neurotransmission via P1-purinoceptors in the rat mesenteric arterial bed.

Authors:  V Ralevic
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and in-vitro study.

Authors:  Roya Bazl; Mohammad Reza Ganjali; Ali-Akbar Saboury; Alireza Foroumadi; Parviz Nourozi; Massoud Amanlou
Journal:  Daru       Date:  2012-10-22       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.